<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>16(3)</volume><submitter>Xue X</submitter><pubmed_abstract>ALG3 has significant modulatory function in the process of tumor development. Yet how ALG3 involves in the advancement of different malignancies isn't fully understood. We performed a pan-cancer assessment on ALG3 utilizing datasets from The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) to examine its tumor-related roles across malignancies and its link to particular molecules and cells in the tumor microenvironment (TME). Furthermore, we focused on breast cancer to examine the influence of ALG3-mediated signaling pathways and intercellular interactions in the advancement of tumors. The biological effects of ALG3 were verified by breast cancer cells. Enhanced ALG3 expression was discovered to be substantially linked to patients' grim prognoses in a number of malignancies</pubmed_abstract><journal>Aging</journal><pagination>2320-2339</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10911369</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Comprehensive analysis of ALG3 in pan-cancer and validation of ALG3 as an onco-immunological biomarker in breast cancer.</pubmed_title><pmcid>PMC10911369</pmcid><pubmed_authors>Wang N</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Hong X</pubmed_authors><pubmed_authors>Chen L</pubmed_authors><pubmed_authors>Luo Y</pubmed_authors><pubmed_authors>Lin Z</pubmed_authors><pubmed_authors>Yao G</pubmed_authors><pubmed_authors>Xue X</pubmed_authors><pubmed_authors>Feng Q</pubmed_authors></additional><is_claimable>false</is_claimable><name>Comprehensive analysis of ALG3 in pan-cancer and validation of ALG3 as an onco-immunological biomarker in breast cancer.</name><description>ALG3 has significant modulatory function in the process of tumor development. Yet how ALG3 involves in the advancement of different malignancies isn't fully understood. We performed a pan-cancer assessment on ALG3 utilizing datasets from The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) to examine its tumor-related roles across malignancies and its link to particular molecules and cells in the tumor microenvironment (TME). Furthermore, we focused on breast cancer to examine the influence of ALG3-mediated signaling pathways and intercellular interactions in the advancement of tumors. The biological effects of ALG3 were verified by breast cancer cells. Enhanced ALG3 expression was discovered to be substantially linked to patients' grim prognoses in a number of malignancies</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Feb</publication><modification>2025-04-20T03:00:59.046Z</modification><creation>2025-04-20T03:00:59.046Z</creation></dates><accession>S-EPMC10911369</accession><cross_references><pubmed>38329424</pubmed><doi>10.18632/aging.205483</doi></cross_references></HashMap>